The role of percutaneous circulatory assist devices in acute myocardial infarction and high-risk percutaneous coronary intervention in the 21st century

Cardiovascular Revascularization Medicine

Volumn 12, Issue 4, 2011, Pages 237-242

  Mahmoudi, Michael ^a   Syed, Asmir I ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

High risk PCI; IABP; Impella; STEMI; TandemHeart

Indexed keywords

ACUTE HEART INFARCTION; AORTA BALLOON; CARDIOGENIC SHOCK; ELECTIVE SURGERY; HEART ASSIST DEVICE; HEMODYNAMICS; HUMAN; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CIRCULATORY ASSIST DEVICE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURGICAL RISK; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ACUTE DISEASE; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION;

EID: 79960716103     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.10.003     Document Type: Review

References (33)

1. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV "High-risk" percutaneous transluminal coronary angioplasty. Am J Cardiol 1988, 61:33G-37G.
2. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO Supported "high risk" coronary angioplasty using intraaortic balloon pump counterpulsation. J Am Coll Cardiol 1990, 15:1151-1155.
3. O'Murchu B, Foreman RD, Shaw RE, Brown DL, Peterson KL, Buchbinder M Role of intraaortic balloon pump counterpulsation in high risk coronary rotational atherectomy. J Am Coll Cardiol 1995, 26:1270-1275.
4. Mullins CB, Sugg WL, Kennelly BM, Jones DC, Mitchell JH Effect of arterial counterpulsation on left ventricular volume and pressure. Am J Physiol 1971, 220:694-698.
5. Weiss AT, Engel S, Gotsman CJ, Shefer A, Hasin Y, Bitran D, Gotsman MS Regional and global left ventricular function during intra-aortic balloon counterpulsation in patients with acute myocardial infarction shock. Am Heart J 1984, 108:249-254.
6. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, Krakauer J, Rubenfire M, Fleming P, Noon G, Oldham N, Killip T, Kantrowitz A Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 1973, 288:979-984.
7. Philips PA, Bergman D Intraoperative application of intraaortic balloon counterpulsation determined by clinical monitoring of the endocardial viability ratio. Ann Thorac Surg 1977, 23:45-52.
8. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968, 203:113-118.
9. Cohen M, Urban P, Christenson JT, Joseph DL, Freedman RJ, Miller MF, Ohman EM, Reddy RC, Stone GW, Ferguson JJ Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J 2003, 24:1763-1770. Benchmark Registry Collaborators.
10. O'Rourke MF, Norris RM, Campbell TJ, Chang VP, Sammel NL Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol 1981, 47:815-820.
11. Kono T, Morita H, Nishina T, Fujita M, Onaka H, Hirota Y, Kawamura K, Fujiwara A Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol 1996, 28:876-881.
12. Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, Lundergan C, Hartmann JR, Talley JD, Frey MJ Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation 1994, 90:792-799.
13. Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O'Neill WW, Grines CL A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol 1997, 29:1459-1467.
14. Van't Hof AWJ, Liem AL, de Boer MJ, Hoorntje JCA, Suryapranata H, Zijlstra F A randomized comparison of intra-aortic balloon pump after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999, 20:659-665.
15. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J 2009, 30:459-468.
16. Brodie BR, Stuckey TD, Hansen C, Muncy D Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999, 85:18-23.
17. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos V, Carlino M, Montorfano M, Di Mario C, Colombo A Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003, 145:700-707.
18. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006, 98:608-612.
19. Perera D, Stables R, Booth J, Thomas M, Redwood S The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design. Am Heart J 2009, 158:910-916 e2.
20. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Vis MM, Koch KT, Paulus WJ, de Mol BA, Tijssen JG, Piek JJ, Baan J Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 2010, 75:187-194.
21. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 2007, 70:532-537.
22. Sjauw KD, Remmelink M, Baan J, Lam K, Engström AE, van der Schaaf RJ, Vis MM, Koch KT, van Straalen JP, Tijssen JG, de Mol BA, de Winter RJ, Piek JJ, Henriques JP Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol 2008, 51:1044-1046.
23. Lam K, Sjauw KD, Henriques JP, Ince C, de Mol BA Improved microcirculation in patients with an acute ST-elevation myocardial infarction treated with the Impella LP2.5 percutaneous left ventricular assist device. Clin Res Cardiol 2009, 98:311-318.
24. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2009, 2:91-96.
25. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrøm T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engström AE, Henriques JP Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009, 54:2430-2434.
26. Henriques JP, Remmelink M, Baan J, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter RJ Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006, 97:990-992.
27. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001, 104:2917-2922.
28. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention 2008, 4:331-337.
29. Gimelli G, Wolff MR Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: a single-center experience. J Invasive Cardiol 2008, 20:642-646.
30. Kar B, Forrester M, Gemmato C, Civitello A, Loyalka P, Myers T, Reynolds D Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol 2006, 18:93-96.
31. Al-Husami W, Yturralde F, Mohanty G, Pastore C, Lotun K, Venesy D, Waxman S, Pyne C, Gossman D, Nesto R, Piemonte T Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol 2008, 20:319-322.
32. Aragon J, Lee MS, Kar S, Makkar RR Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv 2005, 65:346-352.
33. Syed AI, Karkar A, Torguson R, Li Y, Ben-Dor I, Collins SD, Lemesle G, Maluenda G, Xue Z, Scheinowitz M, Kaneshige K, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?. Cardiovasc Revasc Med 2010, 11:91-97.